Viking Global Investors LP Bridge Bio Pharma, Inc. Transaction History
Viking Global Investors LP
- $29.9 Billion
- Q1 2025
A detailed history of Viking Global Investors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 22,055,375 shares of BBIO stock, worth $1.01 Billion. This represents 2.55% of its overall portfolio holdings.
Number of Shares
22,055,375
Previous 25,120,991
12.2%
Holding current value
$1.01 Billion
Previous $689 Million
10.61%
% of portfolio
2.55%
Previous 2.33%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
184MCall Options Held
12.8MPut Options Held
2.09M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$886 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$685 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$572 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$330 Million0.14% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$279 Million73.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.82B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...